 "Q2 earnings, Q2 result")
Dr Lal PathLabs (DLPL) on Friday reported a 16.4 per cent year-on-year (Y-o-Y) increase in consolidated net profit for the September quarter of financial year 2025-26 (Q2 FY26) at ₹152 crore, up from ₹131 crore reported for the same period last year.
Its revenue from operations also rose to ₹731 crore in Q2 FY26, a 10.7 per cent on-year growth from ₹660 crore reported in Q2 FY25.
DLPL attributed the performance to increased testing volumes and its expanding footprint, particularly in Tier-III and Tier-IV towns.
Shankha Banerjee, chief executive officer (CEO) at DLPL, said that Q2 FY26 marked a healthy revenue growth trajectory on the back of robust sample volume growth.
“As we continue to focus on improving patient service, enhancing medical expertise, and network expansion, this momentum is expected to continue,” he added.
Also Read
 "Hospital beds")
 "Dr Lal Pathlabs")
 "The Centre may overshoot the Rs 56,260 crore target for dividend receipts from central public-sector enterprises (CPSEs) set for FY25 and is likely to end up getting around Rs 65,000 crore this financial year, according to a senior government officia")
 "pharma medicine drugs")
 "Ford")
The company’s earnings before interest, tax, depreciation, and amortisation (Ebitda) rose by 10.8 per cent on-year to ₹224 crore in Q2, compared to ₹202 crore recorded in the same period last year.
The company announced an interim dividend of ₹7 per equity share for the financial year 2025-26.
It also declared a 1:1 bonus issue, under which it will issue one fully paid-up equity share for every one fully paid-up equity share held by the shareholders of the company as on the record date.
While November 7 has been kept as the record date for the interim dividend, the record date for the bonus issue will be announced by the company later.
As India’s largest diagnostics service provider, DLPL operates 298 clinical laboratories, including a National Reference Lab in Delhi and Regional Reference Labs in Kolkata, Bengaluru, and Mumbai as of September 30, 2025.
Its network also includes 6,607 patient service centres (PSCs) and 12,365 pick-up points (PUPs), serving individual patients, hospitals, healthcare providers, and corporate clients.
On Friday, DLPL’s stock was up marginally by 1.56 per cent, ending the day’s trade at ₹3,137.05 apiece on the Bombay Stock Exchange (BSE).
 "Special Breaking News")
 "adani")
 "Q2 earnings, Q2")
 "Maruti Suzuki India, Maruti Suzuki")
 "Bajaj Electricals")
